Article Text

Download PDFPDF

OP0240 How strong are the associations of spondyloarthritis-related comorbidities with ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis? a register-based study from sweden
  1. K Bengtsson1,
  2. H Forsblad-d'Elia1,2,
  3. E Lie1,
  4. E Klingberg1,
  5. M Dehlin1,
  6. S Exarchou3,
  7. U Lindström1,
  8. J Askling4,
  9. LT Jacobsson1
  1. 1Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Göteborg
  2. 2Departments of Public Health and Clinical Medicine, Rheumatology, Umeå
  3. 3Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö
  4. 4Clinical Epidemiology Unit and Rheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden


Background Spondyloarthritis (SpA), including ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated SpA (uSpA), is a cluster of rheumatic diseases with some common genetic risk factors. These genetic risk factors are likely to result in associations of varying degree with SpA-related comorbidities such as inflammatory bowel disease (IBD), psoriasis and anterior uveitis. There is also a known association between AS and conduction disturbances and aortic regurgitation. Comparative analyses in the same setting of the strengths of these associations with AS, PsA and uSpA are scarce.

Objectives To assess the strengths of the associations of different SpA-related comorbidities with a diagnosis of AS, PsA and uSpA.

Methods All patients, aged ≥18 years, with AS (n=3884), PsA (n=8706) and uSpA (n=2665) were identified 2001 through 2005, according to specified ICD codes from the Swedish Patient Register. The register contains diagnoses from all visits in inpatient and non-primary outpatient care. Each patient was matched by year of birth, sex and county to five general population (GP) controls identified in the Population Register. Occurrence of SpA-related comorbidities prior to 1 January 2006 were also retrieved from the Swedish Patient Register. Number and proportion of cases (n (%)) with a recorded SpA-related comorbidity prior to 1 January 2006 and corresponding prevalence ratio (PR) with 95% confidence interval (CI) were calculated, overall and stratified for sex.

Results PRs for SpA-related comorbidities were significantly elevated in all SpA subtypes compared to their matched GP controls (Table). PRs were substantially elevated in AS, intermediately elevated in uSpA, whereas only moderately increased in PsA. The results were similar in the sex-stratified analyses (not shown).

Table 1.

Prevalence (%) and corresponding Prevalence Ratio (PR) of SpA-related comorbidities in AS, PsA and uSpA

Conclusions The strongest associations of SpA-related comorbidities were seen with AS, closely followed by uSpA, compatible with a substantial shared etiology and phenotypical expression for patients given these two diagnoses, whereas the associations between PsA and the SpA-related comorbidities were considerably weaker.

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.